FDA Asks Hyloris For More Data On Maxigesic IV

Value Added Medicines Specialist Receives Complete Response Letter From US Agency

 
• By David Wallace
  
Tell Me More Magnifying Glass
The FDA has asked for more information as it examines Maxigesic IV • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Value Added Medicines

More from Products